Sort
39,280 grants matching “leukemia”
Dynamic Epigenetic Mapping of a Stem Cell Differentiation Choice
$742,059Ellen V. Rothenberg · California Institute Of Technology · RC2 · FY2010 · CA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$742,042Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms of non-classical multidrug resistance in cancer
$741,838Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Whole Genome Association Analysis of Hematopoietic Cell Transplant (HCT) Outcome
$741,791Paul J Martin · Fred Hutchinson Cancer Research Center · R01 · FY2018 · HL
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation
$741,625Brian C Betts · University Of Minnesota · R01 · FY2023 · HL
Human Colon Cancer
$740,964Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$740,614Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2022 · AI
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma
$740,587Rodney Balhorn · Shal Technologies, Inc. · R44 · FY2015 · CA
Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation
$740,533Edmund K. Waller · Emory University · R01 · FY2023 · AI
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
$740,321Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes
$740,279Christopher Y Park · New York University School Of Medicine · R01 · FY2020 · CA
SBIR TOPIC 255
$740,277John Fidler · Myelorx, Llc · N43 · FY2011 · CA
THERAPY OF CML
$740,244University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA
Chromatin and epigenetic memory
$740,049Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
$739,531Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing
$739,526James C Sturm · Gpb Scientific, Inc. · R42 · FY2015 · CA
Personalized vaccine for patients with AML
$739,429David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
Immunology And Pathology Of Acute Murine Leukemia Virus Infections
$739,146Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
CD300 receptors regulate efferocytosis, importance in inflammation, cancer and autoimmunity
$738,866John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
$738,832Andrew G Myers · Harvard University · R01 · FY2016 · CA
Project 1 - Clinical Trial
$738,729Andrew R Haas · University Of Pennsylvania · P01 · FY2019 · CA
Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia
$738,698Jeffrey Y Wong · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
NextGen - CRI
$738,441Catherine Mary Bollard · Children'S Research Institute · OT2 · FY2023 · CA
Biochemical Mechanisms of Enzyme Action and Cellular Regulation
$738,300P. Boon Chock · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Improving risk allocation and developing novel therapies for children with T-ALL and T-LL
$737,926David T. Teachey · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA